Key result
Aisap.ai deep learning algorithm detects moderate-to-severe MR with an AUC of ~0.98.
Why the study?
Mitral and tricuspid regurgitation are common and cause substantial morbidity and mortality, but access to diagnostic transthoracic echocardiography remains limited in many settings.
Does the Aisap.ai deep learning algorithm accurately diagnose moderate to severe atrioventricular regurgitation compared to cardiologist interpretation in adult patients undergoing transthoracic echocardiography?
Observational (n=578)
Yes
Does the Aisap.ai deep learning algorithm accurately diagnose moderate to severe atrioventricular regurgitation compared to cardiologist interpretation in adult patients undergoing transthoracic echocardiography?
Effect estimate: AUC 0.98 (95% CI 0.97-0.99)
An FDA-cleared deep learning algorithm demonstrated high diagnostic accuracy in identifying clinically significant mitral and tricuspid regurgitation from limited echocardiographic views, suggesting feasibility for AI-assisted triage in primary and decentralized care settings.
Supports AI triage for moderate-to-severe MR/TR on TTE; leaves open prospective validation before clinical adoption.
Aims: Mitral and tricuspid regurgitation (MR and TR) are common in older adults and associated with substantial morbidity and mortality. While transthoracic echocardiography (TTE) is the diagnostic gold standard, access remains limited in many care settings. Artificial intelligence (AI)-based echocardiographic analysis may help address this diagnostic gap. Methods and results: We externally validated a deep learning algorithm developed by Aisap.ai using TTE studies from the Mayo Clinic Health System (2013-23). The model analyses echocardiographic images to classify atrioventricular regurgitation severity and was evaluated against cardiologist interpretations. Performance was assessed using binary (normal-mild vs. moderate-severe) and ordinal (normal, mild, moderate, severe) classification schemes. Among 1541 eligible TTEs, the model returned predictions for 578 studies (38%). Performance analysis was limited to these cases. The MR cohort included 280 studies and the TR cohort 298. For MR, the model achieved an area under the receiver operating characteristic curve (AUC) of 0.98 [95% confidence interval (CI): 0.97-0.99], with 91% accuracy, 95% sensitivity, and 89% specificity. For TR, the AUC was 0.96 (95% CI: 0.94-0.98), with 84% accuracy, 91% sensitivity, and 80% specificity. Conclusion: In cases where a prediction was generated, the model demonstrated high diagnostic performance in identifying clinically significant atrioventricular regurgitation. These findings support the feasibility of AI-assisted echocardiography in diverse populations, while underscoring the need for technical alignment between model requirements and local acquisition practices to ensure real-world applicability.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (2025) conducted an observational in Atrioventricular regurgitation (Mitral and Tricuspid Regurgitation) (n=578). Aisap.ai deep learning algorithm vs. Cardiologist interpretation (clinical ground truth) was evaluated on Detection of moderate-to-severe mitral regurgitation (AUC 0.98, 95% CI 0.97-0.99). The Aisap.ai deep learning algorithm accurately identified moderate-to-severe mitral regurgitation with an AUC of 0.98 and tricuspid regurgitation with an AUC of 0.96 compared to clinical ground truth.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: